Notice Information
Notice Title
Rituximab and Trastuzumab IV Infusion Vials
Notice Description
Supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to NHSScotland
Lot Information
Rituximab IV Infusion Vials
Supply of rituximab 100mg and 500mg intravenous infusion vials to NHSScotland. The Authority has awarded this framework as an unranked multi-supplier framework per line to a maximum of six (6) Framework Participants.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Trastuzumab IV Infusion VialsSupply of trastuzumab 150mg and 420mg intravenous infusion vials to NHSScotland. The Authority has awarded this framework as an unranked multi-supplier framework per line to a maximum of six (6) Framework Participants.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000610949
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL390001
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £11,000,000 £10M-£100M
- Lots Value
- £33,500,000 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £11,153,779 £10M-£100M
Notice Dates
- Publication Date
- 7 Jul 20205 years ago
- Submission Deadline
- 23 Mar 2020Expired
- Future Notice Date
- Not specified
- Award Date
- 11 Jun 20205 years ago
- Contract Period
- 1 Jul 2020 - 30 Jun 2022 1-2 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- Not specified
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB381545
Rituximab and Trastuzumab IV Infusion Vials - The framework is for the supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to health boards across NHSScotland -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL390001
Rituximab and Trastuzumab IV Infusion Vials - Supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to NHSScotland
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000610949-2020-07-07T00:00:00Z",
"date": "2020-07-07T00:00:00Z",
"ocid": "ocds-r6ebe6-0000610949",
"initiationType": "tender",
"parties": [
{
"id": "org-4",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"email": "rcruickshanks@nhs.net",
"telephone": "+44 1312756840",
"url": "http://www.publictenderscotland.publiccontractsscotland.gov.uk"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-41",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB"
},
"contactPoint": {
"url": "http://",
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
},
"roles": [
"reviewBody"
]
},
{
"id": "org-24",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Stephanie McNiven",
"email": "stephaniemcniven@nhs.net",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-25",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"email": "nss.procurementteam@nhs.net",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-161",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": "Walton Oaks, Dorking Road, Surrey",
"locality": "Tadworth",
"region": "UK",
"postalCode": "KT20 7NS"
},
"contactPoint": {
"telephone": "+44 1737330402",
"faxNumber": "+44 1737330268"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-162",
"name": "Roche Products Ltd",
"identifier": {
"legalName": "Roche Products Ltd"
},
"address": {
"streetAddress": "6 Falcon Way, Shire Park",
"locality": "Welwyn Garden City",
"region": "UK",
"postalCode": "AL7 1TW"
},
"contactPoint": {
"telephone": "+44 1707366171"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-163",
"name": "Napp Pharmaceuticals",
"identifier": {
"legalName": "Napp Pharmaceuticals"
},
"address": {
"streetAddress": "Milton Road , Science Park",
"locality": "Cambridge",
"region": "UK",
"postalCode": "CB4 0AB"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-164",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"streetAddress": "Frimley Business Park, Frimley",
"locality": "Camberley",
"region": "UK",
"postalCode": "GU16 7SR"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-165",
"name": "Amgen Ltd",
"identifier": {
"legalName": "Amgen Ltd"
},
"address": {
"streetAddress": "240 Cambridge Science Park, Milton Road",
"locality": "Cambridge",
"region": "UK",
"postalCode": "CB4 0WD"
},
"contactPoint": {
"telephone": "+44 1223436406",
"faxNumber": "+44 1223228211"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-166",
"name": "MSD",
"identifier": {
"legalName": "MSD"
},
"address": {
"streetAddress": "HERTFORD ROAD",
"locality": "HODDESDON",
"region": "UK",
"postalCode": "EN11 9BU"
},
"contactPoint": {
"telephone": "+44 1992455245"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"id": "org-25"
},
"tender": {
"id": "NP46720",
"title": "Rituximab and Trastuzumab IV Infusion Vials",
"description": "Supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to NHSScotland",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "2"
}
],
"value": {
"amount": 11000000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk",
"tenderPeriod": {
"endDate": "2020-03-23T12:00:00Z"
},
"awardPeriod": {
"startDate": "2020-03-23T12:00:00Z"
},
"documents": [
{
"id": "FEB381545",
"documentType": "contractNotice",
"title": "Rituximab and Trastuzumab IV Infusion Vials",
"description": "The framework is for the supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to health boards across NHSScotland",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB381545",
"format": "text/html"
},
{
"id": "JUL390001",
"documentType": "awardNotice",
"title": "Rituximab and Trastuzumab IV Infusion Vials",
"description": "Supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to NHSScotland",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL390001",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"title": "Rituximab IV Infusion Vials",
"description": "Supply of rituximab 100mg and 500mg intravenous infusion vials to NHSScotland. The Authority has awarded this framework as an unranked multi-supplier framework per line to a maximum of six (6) Framework Participants.",
"status": "complete",
"value": {
"amount": 8500000,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Logistics",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"startDate": "2020-07-01T00:00:00Z",
"endDate": "2022-06-30T00:00:00Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "2",
"title": "Trastuzumab IV Infusion Vials",
"description": "Supply of trastuzumab 150mg and 420mg intravenous infusion vials to NHSScotland. The Authority has awarded this framework as an unranked multi-supplier framework per line to a maximum of six (6) Framework Participants.",
"status": "complete",
"value": {
"amount": 25000000,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Logistics",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"startDate": "2020-07-01T00:00:00Z",
"endDate": "2022-06-30T00:00:00Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
}
],
"lotDetails": {
"maximumLotsBidPerSupplier": 2147483647
},
"bidOpening": {
"date": "2020-03-23T12:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Goods for the commencement of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.",
"minimum": "a)Confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Goods will be in place for the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products."
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true,
"frameworkAgreement": {
"maximumParticipants": 6
}
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.",
"hasRecurrence": false,
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"amendments": [
{
"id": "amd-26",
"description": "Change to ITT response closing date",
"unstructuredChanges": [
{
"oldValue": {
"date": "2020-03-23T12:00:00Z"
},
"newValue": {
"date": "2020-04-07T12:00:00Z"
},
"where": {
"section": "IV.2.2",
"label": "Time limit"
}
},
{
"oldValue": {
"date": "2020-03-23T12:00:00Z"
},
"newValue": {
"date": "2020-04-07T12:00:00Z"
},
"where": {
"section": "IV.2.7",
"label": "Conditions for opening of tenders"
}
}
]
}
]
},
"language": "EN",
"description": "The estimated values referred to in Section II.1.5 and within all Lots covers the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:624794)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000610949"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000610949"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000610949"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP46720-1",
"title": "Rituximab IV Infusion Vials",
"suppliers": [
{
"id": "org-161",
"name": "Pfizer Ltd"
},
{
"id": "org-162",
"name": "Roche Products Ltd"
},
{
"id": "org-163",
"name": "Napp Pharmaceuticals"
},
{
"id": "org-164",
"name": "Sandoz Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "NP46720-2",
"title": "Trastuzumab IV Infusion Vials",
"suppliers": [
{
"id": "org-161",
"name": "Pfizer Ltd"
},
{
"id": "org-162",
"name": "Roche Products Ltd"
},
{
"id": "org-163",
"name": "Napp Pharmaceuticals"
},
{
"id": "org-165",
"name": "Amgen Ltd"
},
{
"id": "org-166",
"name": "MSD"
}
],
"relatedLots": [
"2"
]
}
],
"contracts": [
{
"id": "NP46720-1",
"awardID": "NP46720-1",
"title": "Rituximab IV Infusion Vials",
"status": "active",
"value": {
"amount": 7852589,
"currency": "GBP"
},
"dateSigned": "2020-06-11T00:00:00Z"
},
{
"id": "NP46720-2",
"awardID": "NP46720-2",
"title": "Trastuzumab IV Infusion Vials",
"status": "active",
"value": {
"amount": 3301190,
"currency": "GBP"
},
"dateSigned": "2020-06-11T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2020/S 039-093668"
}
],
"bids": {
"statistics": [
{
"id": "309",
"measure": "bids",
"value": 4,
"relatedLot": "1"
},
{
"id": "310",
"measure": "smeBids",
"value": 0,
"relatedLot": "1"
},
{
"id": "311",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "1"
},
{
"id": "312",
"measure": "foreignBidsFromNonEU",
"value": 0,
"relatedLot": "1"
},
{
"id": "313",
"measure": "electronicBids",
"value": 4,
"relatedLot": "1"
},
{
"id": "314",
"measure": "bids",
"value": 5,
"relatedLot": "2"
},
{
"id": "315",
"measure": "smeBids",
"value": 0,
"relatedLot": "2"
},
{
"id": "316",
"measure": "foreignBidsFromEU",
"value": 0,
"relatedLot": "2"
},
{
"id": "317",
"measure": "foreignBidsFromNonEU",
"value": 0,
"relatedLot": "2"
},
{
"id": "318",
"measure": "electronicBids",
"value": 5,
"relatedLot": "2"
}
]
}
}